StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Siegfried Holding AG
Swiss Stock Exchange:SFZN.SW
Sector
Location
Market Cap
USD 4.98 B
Share Price
USD 113.80
Avg Daily Volume
69,378
Change (1 day)
2.43%
Change (1 year)
-89.88%
Change (YTD)
-89.56%
Siegfried Holding AG Enterprise Value to EBITDA (EV/EBITDA) on July 16, 2025: 17.18
Siegfried Holding AG Enterprise Value to EBITDA (EV/EBITDA) is 17.18 on July 16, 2025, a -8.29% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Siegfried Holding AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 23.05 on July 16, 2025, which is 34.16% above the current Enterprise Value to EBITDA (EV/EBITDA).
-
Siegfried Holding AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 12.73 on July 16, 2025, which is -25.92% below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Siegfried Holding AG average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 18.53.
Competitors
AbbVie Inc.
USD 190.58
ABBV
+4.19
2.25%
Novo Nordisk A/S
USD 67.42
NOVO-B.CO
+0.26
0.39%
Roche Holding AG
USD 338.90
RO.SW
+1.87
0.56%
Novartis AG
USD 118.69
NOVN.SW
-0.95
-0.80%
Abbott Laboratories
USD 131.74
ABT
+0.25
0.19%
AstraZeneca PLC
USD 140.04
AZN.L
-0.39
-0.28%
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
Amgen Inc.
USD 299.02
AMGN
+6.51
2.23%
Pfizer Inc.
USD 24.61
PFE
0.00%
Gilead Sciences, Inc.
USD 109.85
GILD
+0.79
0.72%
Vertex Pharmaceuticals Incorporated
USD 469.55
VRTX
+5.35
1.15%
Sanofi
USD 96.84
SAN.PA
+0.90
0.94%
Bristol-Myers Squibb Company
USD 47.17
BMY
+0.74
1.59%
CSL Limited
USD 160.99
CSL.AX
-0.54
-0.33%
GSK plc
USD 19.08
GSK.L
+0.31
1.65%
Chugai Pharmaceutical Co., Ltd.
USD 46.49
4519.T
+0.50
1.10%
Regeneron Pharmaceuticals, Inc.
USD 547.93
REGN
-0.03
-0.01%
MERCK Kommanditgesellschaft auf Aktien
USD 128.56
MRK.DE
+0.95
0.75%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.00
600276.SS
+0.04
0.51%
Takeda Pharmaceutical Company Limited
USD 29.68
4502.T
+0.09
0.31%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
AbbVie Inc.
USD 190.58
ABBV
+4.19
2.25%
Novo Nordisk A/S
USD 67.42
NOVO-B.CO
+0.26
0.39%
Roche Holding AG
USD 338.90
RO.SW
+1.87
0.56%
Novartis AG
USD 118.69
NOVN.SW
-0.95
-0.80%
Abbott Laboratories
USD 131.74
ABT
+0.25
0.19%
AstraZeneca PLC
USD 140.04
AZN.L
-0.39
-0.28%
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
Amgen Inc.
USD 299.02
AMGN
+6.51
2.23%
Pfizer Inc.
USD 24.61
PFE
0.00%
Gilead Sciences, Inc.
USD 109.85
GILD
+0.79
0.72%
Vertex Pharmaceuticals Incorporated
USD 469.55
VRTX
+5.35
1.15%
Sanofi
USD 96.84
SAN.PA
+0.90
0.94%
Bristol-Myers Squibb Company
USD 47.17
BMY
+0.74
1.59%
CSL Limited
USD 160.99
CSL.AX
-0.54
-0.33%
GSK plc
USD 19.08
GSK.L
+0.31
1.65%
Chugai Pharmaceutical Co., Ltd.
USD 46.49
4519.T
+0.50
1.10%
Regeneron Pharmaceuticals, Inc.
USD 547.93
REGN
-0.03
-0.01%
MERCK Kommanditgesellschaft auf Aktien
USD 128.56
MRK.DE
+0.95
0.75%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.00
600276.SS
+0.04
0.51%
Takeda Pharmaceutical Company Limited
USD 29.68
4502.T
+0.09
0.31%